Stock listing

Mendus Ab

Selected listing: IMMU · OMXSTO · SEK · SE

Mendus Ab (Stockholm:IMMU), Health Technology. Latest release Sep 14, 2026: Mendus draws under the second tranche of the Fenja Capital II A/S loan facility…

IMMU:OMXSTOSEKSEUpdated October 3, 2026

Ticker: Stockholm:IMMU
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Stockholm
Currency: SEK

About Mendus Ab

Mendus Ab is a public company listed on the Swedish market under the ticker IMMU. Mendus Ab focuses on developing innovative therapies in the field of immuno-oncology.

Latest news from Mendus Ab

Mendus draws under the second tranche of the Fenja Capital II A/S loan facility, extending cash runway into the second quarter of 2027

September 14, 2026

MENDUS AB INTERIM REPORT APRIL– JUNE 2026

August 20, 2026

Invitation to presentation of Mendus' second quarter 2026 financial report and business update

August 13, 2026

Change in number of shares and votes in Mendus AB (publ)

July 31, 2026

Mendus AB (publ) has decided on directed issues of Class C shares and transfer of own ordinary shares

June 23, 2026

All Mendus Ab news →

Events

Replays

Mendus AB (publ) (IMMU) Q2 2026 Earnings Call
Thu, Aug 20, 2026 · 08:00 AM ET
Watch
Mendus AB (publ) (IMMU) Q1 2026 Earnings Call
Fri, May 08, 2026 · 08:00 AM ET
Watch
Mendus AB (publ) (IMMU) Q4 2025 Earnings Call
Wed, Feb 11, 2026 · 08:00 AM ET
Watch

Research Mendus Ab

Mendus Ab company profile

View the public company page for Mendus Ab on 6ix.

Mendus Ab news

Read company news and market updates connected to Mendus Ab.

Mendus Ab investor events

Find investor webinars, events, and replay context for Mendus Ab.